MedTrace Logo

Evaluation of the Use of the Colli-Pee Device to Collect First-void Urine for Molecular Detection of STIs

NCT02552914 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 186

Last updated 2018-07-26

No results posted yet for this study

Summary

Study objectives:

* To evaluate the usability of the Colli-PeeTM device to collect first-void urine for nucleic acid detection of Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis and Mycoplasma genitalium.
* To collect feedback on the easiness of use and the willingness of future use of the Colli-PeeTM device.

Conditions

  • Sexually Transmitted Diseases, Bacterial

Interventions

DEVICE

Colli-Pee

Participants will be asked to use the colli-pee to collect first-void urine and to send it back to the Institute of Tropical Medicine by regular mail.

Sponsors & Collaborators

  • Novosanis NV

    collaborator INDUSTRY

  • Institute of Tropical Medicine, Belgium

    lead OTHER

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2018-05-31
Completion
2018-06-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02552914 on ClinicalTrials.gov